Author

M. Todd

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

B. Laleu· 1 shared B. Perry· 1 shared C. Siepker· 1 shared D. E. Stallknecht· 1 shared E. W. Howerth· 1 shared H. P. Duong· 1 shared H. S. Sellers· 1 shared I. Padykula· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Laleu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Randomly primed, strand-switching MinION-based sequencing for the detection and characterization of cultured RNA viruses

K. T. Young, K. K. Lahmers, H. S. Sellers, D. E. Stallknecht, R. L. Poulson, J. T. Saliki, S. M. Tompkins, I. Padykula, C. Siepker, E. W. Howerth, M. Todd, J. B. Stanton

This study evaluates a MinION-based sequencing method for detecting and characterizing RNA viruses using random priming and strand-switching, showing its effectiveness for known and unknown viruses.

bioRxiv · Dec 16, 2019Pathology

Addressing the Most Neglected Diseases through an Open Research Model: the Discovery of Fenarimols as Novel Drug Candidates for Eumycetoma

W. Lim, Y. Melse, M. Konings, H. P. Duong, K. Eadie, B. Laleu, B. Perry, M. Todd, J.-R. Ioset, W. van de Sande

This paper identifies new drug candidates for eumycetoma by screening 800 compounds and testing their in vitro and in vivo activity against Madurella mycetomatis, using an open-source approach to accelerate drug discovery.

bioRxiv · Feb 2, 2018Pharmacology & Toxicology